Bio-Rad Laboratories, INC. (BIO) — SEC Filings
Latest SEC filings for Bio-Rad Laboratories, INC.. Recent ARS filing on Mar 25, 2026. AI-decoded analysis of earnings, risk factors, and insider trades.
View Bio-Rad Laboratories, INC. on SEC EDGAR
Overview
Bio-Rad Laboratories, INC. (BIO) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a ARS filed on Mar 25, 2026: Bio-Rad Laboratories, Inc. (CIK: 0000012208) filed its Annual Report to Security Holders (ARS) on March 25, 2026, covering the period ending December 31, 2025. This routine filing provides shareholders with the company's annual financial performance and operational updates for the past fiscal year.
Sentiment Summary
Across 1 filings, the sentiment breakdown is: 1 neutral. The dominant filing sentiment for Bio-Rad Laboratories, INC. is neutral.
Filing Type Overview
Bio-Rad Laboratories, INC. (BIO) has filed 1 ARS with the SEC between Mar 2026.
Recent Filings (1)
-
Bio-Rad Files 2025 Annual Report to Security Holders
— ARS · Mar 25, 2026
Bio-Rad Laboratories, Inc. (CIK: 0000012208) filed its Annual Report to Security Holders (ARS) on March 25, 2026, covering the period ending December 31, 2025.
Frequently Asked Questions
What are the latest SEC filings for Bio-Rad Laboratories, INC. (BIO)?
Bio-Rad Laboratories, INC. has 1 recent SEC filings from Mar 2026, including 1 ARS. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of BIO filings?
Across 1 filings, the sentiment breakdown is: 1 neutral. The dominant sentiment is neutral.
Where can I find Bio-Rad Laboratories, INC. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Bio-Rad Laboratories, INC. (BIO) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.